General Court annuls harmonised classification of titanium dioxide as carcinogenic: 1 December 2022; On 23 November 2022, in its judgment in joined cases T-279/20, T-283/20 and T-288/20, the General Court considered that the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based. It also found that the Commission infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.

8 November 2022 Can nanoparticles save historic buildings?

Read the latest Nanopinion guest column by Dr. Joanna Dziadkowiec and Prof. Markus Valtiner on how unique properties of nanomaterials could be used to preserve historic buildings.
7 November 2022 European nanomaterial market expected to grow

The latest study by the European Union Observatory for Nanomaterials (EUON) predicts growth in the European nanomaterial market over the period of 2021 - 2025. The study provides a list of nanomaterials currently on the market and identifies key market operators.
12 October 2022 Intelligent material technologies for a sustainable future!

Read the latest Nanopinion guest column from Sesha Manuguri, PhD, on how to use the knowledge obtained from the processes in nature to create smart materials that can dynamically change colours in response to environmental stimuli.

Nanomaterials and health

Are substances in nanoforms more dangerous than they are in their normal size? Some are and some are not. Just like any other chemical substance, nanomaterials have to be assessed separately.

Fighting cancer using nanotechnology

Nanomaterials are not only used in consumer products, but also in new and innovative medical treatments. Research has shown that nanoparticles can be used to damage and even destroy cancer cells from within.